Filing Details
- Accession Number:
- 0001104659-24-125093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:30:17
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-03 16:30:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1644963 | Avenue Therapeutics Inc. | ATXI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298246 | Neil Herskowitz | C/O Avenue Therapeutics, Inc. 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 | Disposition | 2024-12-02 | 23 | $2.00 | 97 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the "Reverse Stock Split") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.